(Q35684119)

9 August 2017

1 reference

title

Gene replacement therapy for non-small cell lung cancer: a review (English)

1 reference

9 August 2017

1 reference

Jack A Roth

1

1 reference

9 August 2017

Susan F Grammer

series ordinal

2

1 reference

9 August 2017

publication date

1 February 2004

1 reference

Hematology / Oncology Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

18

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

215-229

1 reference

Improved DNA: liposome complexes for increased systemic delivery and gene expression

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Mutation Affecting the 12th Amino Acid of the c-Ha- ras Oncogene Product Occurs Infrequently in Human Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Molecular themes in oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Cancer-susceptibility genes. Gatekeepers and caretakers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Animal models of tumor-suppressor genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

The p53 pathway and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

p53 expression and prognosis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Radiation-induced apoptosis: Relevance to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Apoptosis in murine tumors treated with chemotherapy agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: can they predict treatment response and clinical outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

No association between radiosensitivity and TP53 status, G1 arrest or protein levels of p53, myc, ras or raf in human melanoma lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900144-8

7 January 2021

10.1016/S0889-8588(03)00144-8

Identifiers

DOI

1 reference

9 August 2017

1 reference